212 related articles for article (PubMed ID: 32683764)
1. Isotretinoin and the eye: A review for the dermatologist.
Ruiz-Lozano RE; Hernández-Camarena JC; Garza-Garza LA; Bustamante-Arias A; Colorado-Zavala MF; Cardenas-de la Garza JA
Dermatol Ther; 2020 Nov; 33(6):e14029. PubMed ID: 32683764
[TBL] [Abstract][Full Text] [Related]
2. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
Ahmad HM
Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
[TBL] [Abstract][Full Text] [Related]
3. Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment.
Caglar C; Senel E; Sabancilar E; Durmus M
Int Ophthalmol; 2017 Feb; 37(1):197-202. PubMed ID: 27193123
[TBL] [Abstract][Full Text] [Related]
4. Ocular side effects of systemic isotretinoin - a systematic review and summary of case reports.
Lamberg O; Strome A; Jones F; Mleczek J; Jarocki A; Troost JP; Helfrich Y
J Dermatolog Treat; 2023 Dec; 34(1):2213364. PubMed ID: 37248700
[No Abstract] [Full Text] [Related]
5. Adverse effects of isotretinoin: A large, retrospective review.
Brzezinski P; Borowska K; Chiriac A; Smigielski J
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28295859
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin.
Karalezli A; Borazan M; Altinors DD; Dursun R; Kiyici H; Akova YA
Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405
[TBL] [Abstract][Full Text] [Related]
7. Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential.
AlGhamdi KM; Khurram H; Asiri YA; Mandil A
Int J Dermatol; 2011 Sep; 50(9):1094-8. PubMed ID: 22126870
[TBL] [Abstract][Full Text] [Related]
8. Safety issues in isotretinoin therapy.
Hanson N; Leachman S
Semin Cutan Med Surg; 2001 Sep; 20(3):166-83. PubMed ID: 11594672
[TBL] [Abstract][Full Text] [Related]
9. [Isotretinoin administration in treatment of acne vulgaris. A prospective study of the kind and extent of ocular complications].
Egger SF; Huber-Spitzy V; Böhler K; Scholda C
Ophthalmologe; 1995 Feb; 92(1):17-20. PubMed ID: 7719068
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced ocular side-effects with isotretinoin.
Santodomingo-Rubido J; Barrado-Navascués E; Rubido-Crespo MJ
Ophthalmic Physiol Opt; 2008 Sep; 28(5):497-501. PubMed ID: 18761487
[TBL] [Abstract][Full Text] [Related]
11. An adolescent with abdominal pain taking isotretinoin for severe acne.
Greene JP
South Med J; 2006 Sep; 99(9):992-4. PubMed ID: 17004534
[TBL] [Abstract][Full Text] [Related]
12. Patients' Awareness of the Ocular Side Effects of Isotretinoin Therapy: A Study From Saudi Arabia.
AlMasoudi RM; Bahaj RK; Kokandi AA
Cureus; 2022 Apr; 14(4):e24628. PubMed ID: 35664419
[TBL] [Abstract][Full Text] [Related]
13. Isotretinoin Monitoring Trends: A National Survey of Dermatologists.
Hobson JG; Cunningham MJ; Lesiak K; Lester EB; Tegeder AR; Zeeck E; Hugh JM; Lin JH
J Drugs Dermatol; 2017 Jun; 16(6):557-564. PubMed ID: 28686773
[TBL] [Abstract][Full Text] [Related]
14. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
Rademaker M
Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of oral isotretinoin effects on hearing system in patients with acne vulgaris: Reversible or not?
Kemeriz F; Kayabaşı S; Cevirgen Cemil B; Hızlı Ö
Dermatol Ther; 2021 Jan; 34(1):e14640. PubMed ID: 33278063
[TBL] [Abstract][Full Text] [Related]
16. [Second joint position paper: Use of isotretinoin in severe acne].
Gómez-Flores M; Poletti-Vázquez DE; García-Hidalgo L; Fierro-Arias L; Herz-Ruelas M; Garza-Gómez J; Rosas-Ortiz JF
Rev Med Inst Mex Seguro Soc; 2019 Jan; 56(5):441-446. PubMed ID: 30777411
[TBL] [Abstract][Full Text] [Related]
17. Cross-Sectional Assessment of Dermatologists' Knowledge and Attitude Towards Isotretinoin-Related Ocular Side Effects in Aseer, Saudi Arabia.
Korkoman A; Alamri A; Al Zomia AS; Korkoman S; Qahtani SH; Alshahrani YM; Alotaibi TB; Asiri BM; Alqahtani AN; Awwadh OA; Alghamdi BA; Alshahrani A
Cureus; 2023 Oct; 15(10):e46335. PubMed ID: 37920642
[TBL] [Abstract][Full Text] [Related]
18. Ocular adverse effects of systemic treatment with isotretinoin.
Neudorfer M; Goldshtein I; Shamai-Lubovitz O; Chodick G; Dadon Y; Shalev V
Arch Dermatol; 2012 Jul; 148(7):803-8. PubMed ID: 22508771
[TBL] [Abstract][Full Text] [Related]
19. Managing nonteratogenic adverse reactions to isotretinoin treatment for acne vulgaris.
Reilly BK; Ritsema TS
JAAPA; 2015 Jul; 28(7):34-9. PubMed ID: 26107793
[TBL] [Abstract][Full Text] [Related]
20. Premacular hemorrhage due to isotretinoin use.
Onder HI; Turan H; Kilic AC; Kaya M; Tunc M
Cutan Ocul Toxicol; 2013 Jun; 32(2):170-2. PubMed ID: 22510043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
